Dietary Protein Restriction and Health
LOWPRO
Dietary Protein, FGF21 and Glucose Homeostasis
1 other identifier
interventional
23
1 country
1
Brief Summary
The incidence of type 2 diabetes worldwide has increased significantly over the past decades, which is associated with changing dietary habits and physical inactivity. According to the diet, so far there has been a great focus on the quality of carbohydrates and fat in relation to metabolic health, while the importance of protein has been neglected. The Danes' average protein intake is 1.5 g/kg/day, which is at the high end of the recommendations (0.8-1.5 g/kg/day) from the Nordic Nutrition Recommendations (NNR 2023). Recent studies in rodents have shown that protein restriction has positive effects on health, including improved glucose and insulin homeostasis and reduced fat mass, while a high intake of protein has a negative effect on insulin sensitivity. Previously the investigators have shown, in healthy young men, that consuming a diet low in protein (0.9 g/kg/day), compared to the participants usual diet (1.5 g/kg/day), over 7 days, resulted in an increased insulin sensitivity as well as a marked increase in the plasma fibroblast growth factor 21 (FGF21) concentration. The increased insulin sensitivity is thought to be mediated by the increase in plasma FGF21 concentration. However, the effect is not yet fully understood. It is also not clear whether the increase in plasma FGF21 concentration, as well as the mentioned metabolic effects on insulin and glucose homeostasis, will take place if the participants are kept weight stable on a eucaloric diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedFirst Submitted
Initial submission to the registry
February 7, 2024
CompletedFirst Posted
Study publicly available on registry
February 20, 2024
CompletedMay 7, 2024
May 1, 2024
1.8 years
February 7, 2024
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Energy balance
Energy balance was measured in an over-night fasted state via indirect calorimetry expressed in MJ/day prolonged eucaloric dietary protein restriction compared with a higher habitual protein intake
from week 0 to week 10.
Insulin sensitivity
Insulin sensitivity was measured by the hyperinsulinemic, euglycemic clamp procedure
Measured at week 5 (low protein, high carbohydrate diet) and week 5 on habitual diet and at week 5 (low protein high fat diet) and week 5 on habitual diet
Secondary Outcomes (2)
Adipose tissue proteomics
After 5 weeks low protein, high carbohydrate and 5 weeks low protein, high fat. On the tenth week on habitual diet
Plasma FGF21
Every week from week 0 to week 10
Study Arms (3)
Acute meal test
EXPERIMENTALacute intake of a low protein, high carbohydrate diet. No drug intervention
Chronic low protein, high carbohydrate diet
EXPERIMENTALLow protein, high carbohydrate diet and habitual diet. No drug intervention
Low protein , high fat diet
EXPERIMENTALLow protein, high fat diet and habitual diet. No drug intervention
Interventions
The consumption of different diets restricted in protein replaced by either carbohydrate or fat and an habitual diet.
Eligibility Criteria
You may qualify if:
- BMI≤25
- Maximal oxygen uptake ≤42-51 ml/kg/min) • non-smoking
You may not qualify if:
- The use of medicine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Copenhagen
Copenhagen, 2100, Denmark
Study Officials
- PRINCIPAL INVESTIGATOR
Bente Kiens, D.sci, PhD
University of Copenhagen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 7, 2024
First Posted
February 20, 2024
Study Start
May 1, 2018
Primary Completion
January 31, 2020
Study Completion
January 31, 2024
Last Updated
May 7, 2024
Record last verified: 2024-05